A variety of diseases can affect the health of the kidneys. We care for patients at every stage of kidney disease, offering scientifically proven treatments and a personalized care plan. The Department of Urology is part of the Living Donor Transplant Program at the Yale New Haven Transplantation Center where we care for patients with renal disease who are candidates for kidney transplantation. We have expertise in performing laparoscopic, living-donor nephrectomies, delivering the highest quality care to the kidney donor-patient team at Yale. At Yale Medicine, our patients have full access to leading physicians who can help with all aspects of renal disease. Patients also have access to world-class resources at Smilow Cancer Hospital at Yale New Haven. Our doctors are at the forefront of kidney disease and kidney cancer treatment and research, including novel immunotherapy approaches and the genetic characterization of kidney cancers. In addition, the Yale School of Medicine's Hereditary Kidney Cancer and Genetic Assessment Program investigates potential genetic causes of kidney cancer in young patients, including those with a family history and individuals with multiple tumors, to help family members determine if they carry a risk for kidney cancer.

The Yale Medicine Interventional Radiology (IR) program is one of the leading programs in the nation. Our interventional radiologists, recognized as pioneers in the field of minimally invasive medicine, work with nursing and technologist staff to offer image-guided, non-surgical treatments for vascular and non-vascular disease with excellent outcomes for pediatric and adult patients. Our interventional radiology procedures are performed for a broad range of conditions spanning gastrointestinal/hepatobiliary, gynecology, infectious disease, oncology , pediatrics, pain management, urology, and venous and arterial disease. Interventional radiologists use advanced imaging modalities including ultrasound, fluoroscopy, computed tomography, and magnetic resonance imaging to perform procedures through tiny pinholes, thereby avoiding surgery and long recovery times. IR advances enable minimally invasive treatment of many conditions on an outpatient basis, allowing patients to recover in the comfort of their own home. We also offer comprehensive care dedicated to the treatment of pediatric patients, including vascular malformations, biopsy service with sedation, feeding tube maintenance, and expert care in hepatobiliary, urological, gastrointestinal, and musculoskeletal disorders. Our team at Yale New Haven Hospital was the first in Connecticut and among the first in the nation to perform transcatheter pulmonary embolectomy, a procedure for the removal of a blood clot from the pulmonary arteries. Such patients are initially evaluated by a multidisciplinary Pulmonary Embolism Response Team (PERT) , and a comprehensive treatment plan is then developed. We also have one of the world’s leading hereditary hemorrhagic telangiectasia (HHT) and vascular malformation programs. Founded in 1994, both serve as role models for other programs around the world. We offer a wide range of minimally invasive Interventional Radiology treatments, all available at Yale New Haven Hospital. Heart and vascular Angiography, angioplasty, and stenting for arterial disease Embolization for acute, traumatic gastrointestinal and genitourinary bleeding Endovascular treatment of aneurysms and pseudoaneurysms Inferior vena cava filter placement and removal Non-surgical dialysis fistula creation and repair Pulmonary embolectomy to remove pulmonary embolism (blood clot in the lungs) Treatment of arteriovenous malformations Venography, venous stenting, and related procedures for venous occlusion and clot Venous ablation for varicose veins Gastrointestinal/Hepatobiliary Gastrojejunostomy placement and gastrostomy for nutrition Transjugular intrahepatic portosystemic shunt (TIPS) placement for upper GI bleeding and refractory ascites Treatment of benign and malignant bile duct obstructions Treatment of fluid collections in the abdomen, chest, and pelvis Gynecology Fallopian tube recanalization for infertility Uterine fibroid embolization for fibroids and uterine artery embolization fo

The Yale Avascular Necrosis & Osteonecrosis program focuses on maintaining joint function in patients with avascular necrosis (AVN), a condition in which bone tissue dies as a result of a temporary or permanent loss of blood supply to the bone. Our patients receive coordinated care across a spectrum of treatments, including 3D surgical planning, regenerative medicine, osteoinductive adjuvants, hyperbaric oxygen treatments, and stem cell therapies. The goal is to provide the best opportunity for patients to maintain their native joints, as well as continuity, if they eventually require total joint replacement. As a leader in AVN treatments, our innovative program merges evidence-based regenerative medicine with novel surgical techniques. AVN and osteonecrosis can be medically complex. Coordination of services is necessary to understand the cause of the disease, evaluate the extent of the necrosis, and prevent further occurrences. Our program directly works with Yale School of Medicine’s Hematology, Oncology, Infectious Disease, Pathology, Radiology, and Alcohol Cessation services to help streamline care for patients and their families. We offer the following treatments for AVN- and osteonecrosis-related conditions: Hip and knee Lesion treatment: We offer a minimally invasive 3D personalized surgery to address AVN of the hip joint. This procedure, developed at Yale School of Medicine by a team of biomedical engineers, aims to improve patient outcomes and reduce the need for total joint replacement. Shoulder lesion treatment: We treat AVN-related shoulder conditions, with the goal of preserving the shoulder joint whenever possible. Our physicians are experts at both traditional and reverse total shoulder replacement surgery as well as minimally invasive techniques to allow patients to return to their normal activities as soon as possible. Foot and Ankle lesion treatment: Our specialists have developed treatment options for AVN of the foot and ankle joints that range from traditional, conservative approaches, such as generic or custom braces, to surgical management, including joint-preserving or -sacrificing procedures. The treatment options are tailored to each patient, depending on the stage and extent of their necrosis. Hand and Elbow lesion treatment: Our Hand & Upper Extremity experts offer treatment for Keinbock’s disease, Hegemann's disease, and Panner's disease. These include custom braces, joint-preserving procedures, and surgical treatments. Our specialists design treatment plans based on each patient’s stage of necrosis to improve functionality and quality of life. Hyperbaric oxygen treatment: Our specialists are recognized experts in the use of hyberbaric oxygen for the treatment of AVN with the femoral head. Our team is able to create individualized treatment plans for patients seeking this procedure. Stem cell treatment: During the procedure, a patient’s bone marrow is harvested, and stem cel